Dementia (non-Alzheimer) - new pharmaceutical treatments [ID380] | Guidance and guidelines

Status	Suspended
Process	MTA
Referral date	01 March 2003
Topic area	Central nervous system Mental health and behavioural conditions Therapeutic procedures

Information meeting with consultees:	25 March 2004
Closing date for invited submissions / evidence submission:	03 June 2004
Final scope published:	February 2004
1st appraisal committee meeting:	01 January 2100
2nd appraisal committee meeting:	25 January 2005

Assessment Group / Evidence Review Group:	Southampton Health Technology Assessment Centre (SHTAC), University of Southampton
Communications manager:	Phil Ranson
Executive Lead:	Andrew Dillon
Project manager:	Alana Miller
Technical Lead:	Alastair Fischer

Manufacturers / Sponsors	Eisai Ltd
	Shire Pharmaceuticals Ltd
Others	Bath and North East Somerset PCT
	Department of Health
	North Tees PCT
	Welsh Assembly Government
Patient / Carer Groups	Age Concern Cymru
	Age Concern England
	Alzheimer's Society
	Carers UK
	Carers Wales
	CJD Support Network
	Counsel and Care for the Elderly
	Dementia Care Trust
	Different Strokes
	Help the Aged
	Huntington's Disease Association
	Mental Health Foundation
	MIND
	Network of Self Help HIV & Aids Groups
	Neurological Alliance
	Parkinson's Disease Society
	Pick's Disease Support Group
	SANE
	Stroke Association
	Terence Higgins Trust
	UK Coalition of People Living With HIV and AIDS
Professional Groups	British Association of Neurologists
	British Association of Stroke Physicians
	British Geriatrics Society
	British Neuropsychiatry Association
	For Dementia
	Royal College of General Practitioners
	Royal College of Nursing
	Royal College of Physicians
	Royal College of Psychiatrists
	Royal Pharmaceutical Society

Assessment Team	None
Associated Guideline Groups	None
Associated Public Health Groups	None
Comparator Manufacturers	None
General	British Medical Association
	British National Formulary
	National Collaborating Centre for Chronic Conditions
	National Public Health Service for Wales
	NHS Confederation
	NHS Purchasing and Supplies Agency
	NHS Quality Improvement Scotland
Research Groups	Alzheimer's Research Trust
	British Stroke Research Group
	Cochrane Stroke Group
	Creutzfeldt-Jakob Disease Surveillance Unit
	Dementia Research Group and Department of Old Age Psychiatry, Institute of Psychiatry
	Institute for Ageing and Health
	Institute of Neurology
	Research Institute for the Care of the Elderly

Date	Update
10 February 2004	Date of Information Meeting for Consultees added.
12 March 2004	Expected date of issue amended to May 2005.
11 June 2004	This appraisal has now been halted following confirmation received by the Institute from the manufacturers that they have withdrawn the application to extend the license of donepezil within the European Union to include the treatment of vascular dementia while further data is obtained. The Institute will continue to monitor the progress of marketing authorisation of interventions for non-Alzheimer dementia and will contact consultees and commentators at such time as may be appropriate to resume the appraisal.